Back
Fifth Third Bancorp Vs. Dyne Therapeutics Industry Stock Comparison
Buy
66
FITB
Fifth Third Bancorp
Last Price:
47.27
Seasonality Move:
3.96%
Sell
46
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Buy
66
Fifth Third Bancorp (FITB)
is a Buy
Is Fifth Third Bancorp a Buy, Sell or Hold?
- The current Fifth Third Bancorp [FITB] share price is $47.26. The Score for FITB is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- FITB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FITB Stock Price Chart
What is Fifth Third Bancorp's stock price today?
-
The Fifth Third Bancorp share price today is $47.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FITB is experiencing slight selling pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $30.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
FITB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 67.44 | Buy |
| Chaikin Money Flow: | -102699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.16 - 46.14) | Buy |
| Bollinger Bands (100): | (38.93 - 44.25) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 47.11 | Sell |
| Chaikin Money Flow: | -1019710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.92 - 33.44) | Sell |
| Bollinger Bands (100): | (31.39 - 42.57) | Sell |
FITB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.38 | Buy |
| 20-day SMA: | 44.78 | Buy |
| 50-day SMA: | 43.42 | Buy |
| 200-day SMA: | 38.73 | Buy |
| 8-day EMA: | 46.39 | Buy |
| 20-day EMA: | 45.17 | Buy |
| 50-day EMA: | 43.66 | Buy |
| 200-day EMA: | 39.13 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.77 | Buy |
| 20-day SMA: | 30.55 | Sell |
| 50-day SMA: | 32.55 | Sell |
| 200-day SMA: | 32.11 | Sell |
| 8-day EMA: | 30.26 | Buy |
| 20-day EMA: | 30.69 | Sell |
| 50-day EMA: | 32.85 | Sell |
| 200-day EMA: | 30.82 | Sell |
Fifth Third Bancorp Earnings Growth & FITB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.32 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.
Fifth Third Bancorp Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||